Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 4,418,000 | 4,250,000 | 3,800,000 | 3,653,000 | 3,802,000 |
| Cost of Goods | 1,954,000 | 1,783,000 | 1,679,000 | 1,640,000 | 1,703,000 |
| Gross Profit | 2,464,000 | 2,467,000 | 2,121,000 | 2,013,000 | 2,099,000 |
| Operating Expenses | 1,699,000 | 1,279,000 | 1,046,000 | 1,179,000 | 1,827,000 |
| Operating Income | 765,000 | 1,188,000 | 1,075,000 | 834,000 | 272,000 |
| Other Income | -45,000 | -3,000 | -157,000 | -35,000 | 114,000 |
| Pre-tax Income | 720,000 | 1,185,000 | 918,000 | 799,000 | 386,000 |
| Income Tax | -53,000 | 133,000 | 118,000 | 85,000 | -6,000 |
| Net Income Continuous | 771,000 | 1,052,000 | 800,000 | 714,000 | 379,000 |
| Minority Interests | 2,000 | 2,000 | 3,000 | 1,000 | N/A |
| Net Income | $771,000 | $1,050,000 | $797,000 | $713,000 | $379,000 |
| EPS Basic Total Ops | 0.86 | 1.17 | 0.89 | 0.80 | 0.43 |
| EPS Basic Continuous Ops | 0.86 | 1.17 | 0.89 | 0.80 | 0.43 |
| EPS Diluted Total Ops | 0.85 | 1.15 | 0.88 | 0.79 | 0.42 |
| EPS Diluted Continuous Ops | 0.84 | 1.14 | 0.87 | 0.78 | 0.42 |
| EBITDA(a) | $1,015,000 | $1,447,000 | $1,308,000 | $1,069,000 | $512,000 |